Table 4.
JAK2 inhibitors under clinical development in patients with MF
JAK2 inhibitors under clinical development in patients with MF

NA indicates not available.

*Includes patients receiving placebo (COMFORT-I) or “best-available therapy” (COMFORT-II).

or Create an Account

Close Modal
Close Modal